Hodgkin Lymphoma Perspective

• Episode 3: Immunotherapy in Advanced and Metastatic Breast Cancer   Drs Banu Arun and Kevin Kalinsky discuss immunotherapy in the treatment of advanced and metastatic breast cancer, including recent studies, side effects, access to treatment, and disparities in care.
  Medscape, June 07, 2023
• Episode 1: ADCs and Advanced and Metastatic Breast Cancer   Drs Banu Arun and Filipa Lynce discuss what the future holds for antibody-drug conjugates in different metastatic breast cancer subgroups, including efficacy, strategies, and toxicities.
  Medscape, May 02, 2023
• The 4 Ps of Cancer Care: Policy, Politics, Priorities, and Prevention   AstraZeneca's David Fredrickson is encouraged by the latest cancer research and discusses the four Ps: Policy, Politics, Priorities, and Prevention.
  WebMD, March 07, 2023
• Standard-of-Care Therapy in Lung Cancer: Be Open to New Ideas   Dr Mark Kris discusses topics for consideration brought up during a meeting of thoracic oncology practitioners.
  Medscape Oncology, February 27, 2023
• S2 Episode 1: Immunotherapy and Small Cell Lung Cancer   Drs Jacob Sands and Jared Weiss discuss subtypes; ongoing clinical trials; durable, ongoing responses to therapy; and the potential for using the word 'cure' in the treatment of small cell lung cancer.
  Medscape, February 16, 2023
• Physicians of the Year 2022: Best and Worst Find out more on the good deeds and groundbreaking research findings that define the best physicians of the past year — and just how bad the worst doctors could be.
  Medscape Features Slideshows, December 30, 2022
• Had My Patient Come In Today, We May Have Had Other Options Only around 3% of nonsquamous NSCLC tumors carry HER2 mutations, and they are associated with female sex, never-smokers, and a poor prognosis. Now these patients can be offered a targeted therapy.
  MDedge, October 05, 2022
• EHA 2022 Read clinically focused news coverage of key developments from EHA 2022
  Medscape Oncology, June 07, 2022
• Is the Epstein-Barr Virus Associated With COVID-19?   Dr Paul Auwaerter discusses recent studies investigating the potential association of the Epstein-Barr virus with COVID-19.
  Medscape Infectious Diseases, March 17, 2022
• 5 Things to Know About New Pneumococcal Vaccine Guidance Adult pneumococcal vaccine recommendations have been considered some of the most complicated vaccine recommendations to appropriately implement. The good news: Implementation just got simpler.
  CDC Expert Commentary, February 17, 2022
• EHA 2021 Read clinically focused news coverage of key developments from EHA 2021
  Medscape Oncology, June 11, 2021
• Cardiologists, Oncologists Desperately Need Your Help   Oncologists and cardiologists need to collaborate to optimize outcomes for patients with cancer and long-term survivors. Will a new subspecialty emerge?
  Mayo Clinic, June 29, 2020
• ASCO 2020: GI Cancer Highlights From David Kerr   Dr David Kerr discusses recent data on colorectal cancer, presented at the virtual ASCO meeting.
  Medscape Oncology, June 26, 2020
• EHA 2020 Read clinically focused news coverage of key developments from EHA 2020
  Medscape Oncology, June 15, 2020
• Updated Pneumococcal Vaccine Recommendations for Older Adults   What do the new PCV13 recommendations mean, and how do you implement them in your practice? Here's what you need to know.
  CDC Expert Commentary, January 31, 2020
• Relapsed Hodgkin: A Second Chance for Success: Targeted Agents and Immunotherapies   For patients ineligible for transplant or who progress after transplant, options including a targeted antibody-drug conjugate, and immunotherapies are discussed.
  Medscape TV, November 04, 2019
• Chronic Lymphocytic Leukemia: 5 Things to Know The most common adult leukemia has seen a rush of new evidence in recent years. Here are some of the highlights.
  Medscape Oncology, September 24, 2019
• Relapsed Hodgkin: A Second Chance for Success: Benefits of Transplant   Hematologists discuss autologous stem cell transplantation as an option in Hodgkin lymphoma and report on factors for achieving a successful outcome.
  Medscape TV, September 05, 2019
• Relapsed Hodgkin: A Second Chance for Success   University of Nebraska hematologists explore treatment options for relapsed/refractory Hodgkin lymphoma and discuss the importance of autologous stem cell transplantation and targeted agents.
  Medscape TV, July 01, 2019
• EHA 2019 Read clinically focused news coverage of key developments from EHA 2019
  Medscape Oncology, June 10, 2019